Hala Ahmadieh, Sami T Azar, Najla Lakkis, Asma Arabi
{"title":"2型糖尿病患者维生素d缺乏症与疾病控制及并发症的关系","authors":"Hala Ahmadieh, Sami T Azar, Najla Lakkis, Asma Arabi","doi":"10.1155/2013/641098","DOIUrl":null,"url":null,"abstract":"<p><p>Aims. This study aims at assessing the relationship between 25 (OH) vitamin D (25-OHD) levels and microvascular complications in patients with type 2 diabetes mellitus (DM2). Methods. 136 patients (59 ± 11 years) with DM2 (disease duration 8.6 ± 7 years) participated in this cross-sectional study. Anthropometric data, HbA1c, 25-OHD levels, serum creatinine, and urine microalbumin/creatinine ratio were collected. Dilated retinal exam was performed, and diabetic neuropathy was assessed using the United Kingdom Screening Score. Results. Serum 25-OHD correlated negatively with HbA1c (r = -0.20, P = 0.049). Mean 25-OHD levels were lower in subjects with diabetic retinopathy compared to those without retinopathy (12.3 ± 5.5 versus 21.8 ± 13.7, P < 0.001) and lower in subjects with diabetic neuropathy compared to those without neuropathy (16.4 ± 10.4 versus 23.5 ± 14.5, P = 0.004). After adjustment for BMI, diabetes duration, and smoking, 25-OHD was an independent predictor of HbA1c ( β -0.14; P = 0.03). After adjustment for HbA1c, age, smoking, BMI and disease duration, 25-OHD were independent predictors for diabetic retinopathy: OR 2.8 [95% CI 2.1-8.0] and neuropathy: OR 4.5 [95% CI 1.6-12] for vitamin D < 20 versus vitamin D ≥ 20 ng/mL. Conclusion. Low serum 25-OHD level was an independent predictor of HbA1c, diabetic neuropathy, and diabetic retinopathy in patients with DM2. </p>","PeriodicalId":89576,"journal":{"name":"ISRN endocrinology","volume":"2013 ","pages":"641098"},"PeriodicalIF":0.0000,"publicationDate":"2013-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2013/641098","citationCount":"98","resultStr":"{\"title\":\"Hypovitaminosis d in patients with type 2 diabetes mellitus: a relation to disease control and complications.\",\"authors\":\"Hala Ahmadieh, Sami T Azar, Najla Lakkis, Asma Arabi\",\"doi\":\"10.1155/2013/641098\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Aims. This study aims at assessing the relationship between 25 (OH) vitamin D (25-OHD) levels and microvascular complications in patients with type 2 diabetes mellitus (DM2). Methods. 136 patients (59 ± 11 years) with DM2 (disease duration 8.6 ± 7 years) participated in this cross-sectional study. Anthropometric data, HbA1c, 25-OHD levels, serum creatinine, and urine microalbumin/creatinine ratio were collected. Dilated retinal exam was performed, and diabetic neuropathy was assessed using the United Kingdom Screening Score. Results. Serum 25-OHD correlated negatively with HbA1c (r = -0.20, P = 0.049). Mean 25-OHD levels were lower in subjects with diabetic retinopathy compared to those without retinopathy (12.3 ± 5.5 versus 21.8 ± 13.7, P < 0.001) and lower in subjects with diabetic neuropathy compared to those without neuropathy (16.4 ± 10.4 versus 23.5 ± 14.5, P = 0.004). After adjustment for BMI, diabetes duration, and smoking, 25-OHD was an independent predictor of HbA1c ( β -0.14; P = 0.03). After adjustment for HbA1c, age, smoking, BMI and disease duration, 25-OHD were independent predictors for diabetic retinopathy: OR 2.8 [95% CI 2.1-8.0] and neuropathy: OR 4.5 [95% CI 1.6-12] for vitamin D < 20 versus vitamin D ≥ 20 ng/mL. Conclusion. Low serum 25-OHD level was an independent predictor of HbA1c, diabetic neuropathy, and diabetic retinopathy in patients with DM2. </p>\",\"PeriodicalId\":89576,\"journal\":{\"name\":\"ISRN endocrinology\",\"volume\":\"2013 \",\"pages\":\"641098\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2013-10-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1155/2013/641098\",\"citationCount\":\"98\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ISRN endocrinology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/2013/641098\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2013/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ISRN endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2013/641098","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2013/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 98
摘要
目标本研究旨在探讨25 (OH)维生素D (25- ohd)水平与2型糖尿病(DM2)患者微血管并发症的关系。方法:136例DM2患者(59±11岁)(病程8.6±7年)参与横断面研究。收集人体测量数据、HbA1c、25-OHD水平、血清肌酐和尿微量白蛋白/肌酐比值。进行扩张性视网膜检查,并使用英国筛查评分评估糖尿病神经病变。结果。血清25-OHD与HbA1c呈负相关(r = -0.20, P = 0.049)。糖尿病视网膜病变患者的平均25-OHD水平低于无视网膜病变患者(12.3±5.5比21.8±13.7,P < 0.001),糖尿病神经病变患者的平均25-OHD水平低于无神经病变患者(16.4±10.4比23.5±14.5,P = 0.004)。在调整BMI、糖尿病病程和吸烟后,25-OHD是HbA1c的独立预测因子(β -0.14;P = 0.03)。在调整了HbA1c、年龄、吸烟、BMI和疾病持续时间后,25-OHD是糖尿病视网膜病变的独立预测因子:OR为2.8 [95% CI 2.1-8.0],维生素D的神经病变OR为4.5 [95% CI 1.6-12]
Hypovitaminosis d in patients with type 2 diabetes mellitus: a relation to disease control and complications.
Aims. This study aims at assessing the relationship between 25 (OH) vitamin D (25-OHD) levels and microvascular complications in patients with type 2 diabetes mellitus (DM2). Methods. 136 patients (59 ± 11 years) with DM2 (disease duration 8.6 ± 7 years) participated in this cross-sectional study. Anthropometric data, HbA1c, 25-OHD levels, serum creatinine, and urine microalbumin/creatinine ratio were collected. Dilated retinal exam was performed, and diabetic neuropathy was assessed using the United Kingdom Screening Score. Results. Serum 25-OHD correlated negatively with HbA1c (r = -0.20, P = 0.049). Mean 25-OHD levels were lower in subjects with diabetic retinopathy compared to those without retinopathy (12.3 ± 5.5 versus 21.8 ± 13.7, P < 0.001) and lower in subjects with diabetic neuropathy compared to those without neuropathy (16.4 ± 10.4 versus 23.5 ± 14.5, P = 0.004). After adjustment for BMI, diabetes duration, and smoking, 25-OHD was an independent predictor of HbA1c ( β -0.14; P = 0.03). After adjustment for HbA1c, age, smoking, BMI and disease duration, 25-OHD were independent predictors for diabetic retinopathy: OR 2.8 [95% CI 2.1-8.0] and neuropathy: OR 4.5 [95% CI 1.6-12] for vitamin D < 20 versus vitamin D ≥ 20 ng/mL. Conclusion. Low serum 25-OHD level was an independent predictor of HbA1c, diabetic neuropathy, and diabetic retinopathy in patients with DM2.